OptimizeRx's Karina Castagna Named to MM+M's 40 Under 40 List of the Medical Marketing Industry's Brightest Young StarsGlobeNewsWire • 02/09/23
Strength Seen in OptimizeRx Corp. (OPRX): Can Its 10.1% Jump Turn into More Strength?Zacks Investment Research • 01/05/23
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/04/23
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired EventGlobeNewsWire • 10/20/22
OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ETGlobeNewsWire • 10/19/22
OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE SolutionGlobeNewsWire • 10/11/22
OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement ProgramGlobeNewsWire • 08/23/22
OptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
UPDATE – OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-DispenseGlobeNewsWire • 08/10/22
OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-DispenseGlobeNewsWire • 08/09/22
OptimizeRx Corp. (OPRX) Reports Next Week: What to Know Ahead of the ReleaseZacks Investment Research • 08/02/22
OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ETGlobeNewsWire • 07/21/22
OptimizeRx Corp. (OPRX) Moves 8.9% Higher: Will This Strength Last?Zacks Investment Research • 06/27/22
OptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In ProfitabilitySeeking Alpha • 06/27/22
OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive PartnershipGlobeNewsWire • 06/23/22